Full Name
Dr Richard Alm
Job Title
Director of Alliances & Consultant - WHO
Company
CARB-X
Speaker Bio
Richard joined CARB-X as an Alliance Director following almost 20 years in large pharma infection R&D teams followed by 4 years at a small antibacterial biotechnology company. He has supported the progression of multiple programs from early discovery through to late-stage clinical development. He obtained his PhD in molecular microbiology from the University of Adelaide, and prior to joining industry he held two post-doctoral positions in the AMR area, one in Australia and one in Canada.
Speaking At
OPENING REMARKS: Overview of the latest progressions in the clinical landscape for phage-based application
PANEL: Securing financial support from the public, private & philanthropic sectors to continue innovation in phage-based applications
PANEL: Concluding Thoughts from the Phage Futures Congress 2021
Richard Alm